Tom Bourne is Adjunct Professor & Research Team Leader in Dept of Surgery & Cancer, Imperial College London & Visiting Professor, KU Leuven, Belgium. He is Consultant Gynaecologist at Queen Charlotte’s & Chelsea Hospital, London. He is an authority in early pregnancy complications, emergency gynaecology & gynaecological ultrasound.
He has edited 7 books, published >300 papers & been invited to speak at numerous international meetings. His H-index is 44 (Web of Science) & 68 (Google Scholar). He is on the Board & is Treasurer of the International Society for Ultrasound in Obstetrics & Gynecology, President of the Association of Early pregnancy units, & Trustee of the Ectopic Pregnancy Trust. He is chair of the early pregnancy clinical studies group & sits on the research committee at the Royal College of Obstetricians & Gynaecologists. He is on the steering committee of International Ovarian Tumor Analysis trial. He sat on the Society of Radiologists in Ultrasound panel developing guidelines for diagnosing miscarriage in the USA (2012), the American Institute of Ultrasound in Medicine guidelines panel for diagnosing ovarian cancer(2014), and the American College of Radiology committee for ovarian cancer diagnosis(2016).
My current research is related to autoimmune diseases, where we develop and express and characterize specific AIM biologicals as tools against diseases like Type 1 diabetes, Multiple Sclerosis, NMO, and Parkinson's disease. Apart from that, I am interested in the development of novel cancer therapies with a particular focus on Multiple Myeloma, but also investigating other solid tumors. And a last major interest is related to pregnancy and understanding more about the role of Thrombin in terms of cytokine regulation and its functional consequences for trophoblast cells.
Dr Martin Daumer: Director of the SLCMSR e.v. - The Human Motion Institute in Munich and managing director of the IT company, Trium Analysis Online GmbH. He is also visiting lecturer for Telemedicine and Clinical Applications of Computational Medicine at the Technical University Munich.
Dr Daumer received a diploma in Physics in 1990 and a Ph.D. in mathematics from the Ludwig-Maximilians-University Munich in 1995, after having worked at CERN, Switzerland, and Rutgers University, USA.
Dr. Sule Dogan has BSc in Biology from Ankara University, MSc in Embryology and another Master’s degree in science education, both from Dokuz Eylul University in Turkey. After completing her Andrology and Embryology training, she worked at the IVF Clinic of Dokuz Eylul University Medical School between 2007 and 2009. She completed her PhD in Life Sciences/ Genetics program at Mississippi State University. Dr. Dogan joined IVF Michigan Fertility Centers as an embryologist in 2013, started serving as the quality control and laboratory supervisor in 2015 and then became the laboratory director in 2019. She has opened up new andrology laboratories, trained many andrologists and embryologists. She is currently serving as the director of laboratory operations in many locations of IVF Michigan and IVF Ohio Fertility Centers. Dr. Dogan is a certified by ABB as Technical Supervisor in Andrology and Embryology, and as High Complexity Lab Director (HCLD). She has many publications in international journals, including many book chapters. Dr. Dogan has been serving as a reviewer for scientific journals and conferences since 2010.
Khalid El Bairi is the founder of The Cancer Biomarkers Working Group, and he is currently pursuing clinical and translational research in medical oncology. He has published many peer-reviewed articles in the field of predictive and prognostic cancer biomarkers to improve survival outcomes in several WoS and Medline-indexed journals. His research focuses particularly on biomarkers for digestive and gynecological cancers such as ovarian and colorectal malignancies. He is currently a member of the board of various international scientific societies such as the International Gynecologic Cancer Society (IGCS), European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), European Society of Gynaecological Oncology (ESGO), and the American Association for Cancer Research (AACR). He is also an editor and reviewer for more than 40 journals including BMC Cancer, PLoS ONE and Frontiers in Oncology and a guest editor for several special issues on gynecological cancers including Seminars in Cancer Biology and Current Drug Targets. He is also highly interested in teaching evidence-based medicine, clinical research methods, and publishing ethics to medical and Ph.D students and was selected for the 70th Lindau Nobel Laureate Meeting as a young scientist.
Professor, Director of maternity "D" Department and Obstetrical Day care Center , Soroka University Medical Center,Faculty of Health Science, Ben Gurion University of The Negev, Israel. Research Areas: Hypertension In Pregnancy, Coagulation and Hemostasis In Normal and Complicated Pregnancies, Preterm Labor, preterm PROM, IUGR, Stillbirth.
The Development of therapeutic modalities in the field of preterm labor and preeclampsia.
Prof. Maria Elena Flacco is Associate Professor of Epidemiology, Medical Statistics and Public Health at the University of Ferrara, Italy. Her areas of research include epidemiology, public and occupational health, and biostatistics and methods.
Associate Professor of Obstetrics and Gynecology of the University of Milan-Bicocca, in Monza, Italy and staff physician in the general Gynecological Unit of San Gerardo Hospital. Before MD graduation and during the residency in Obstetrics and Gynecology he conducted an intense preclinical research activity at Mario Negri Institute (Milan) and at Massachusetts General Hospital (Boston). In 2010 he acquired a PhD in Gynecologic Oncology. His research interests are focused on molecular biology of ovarian cancer, and on prevention and treatment of gynecological malignancies.
2001: Degree in Medicine and Surgery
2006: Specialization in Obstetrics and Gynecology
2010: PhD in Gynecologic Oncology
2014: Associate Professor in Obstetrics and Gynecology
Dr. Luca Giannella is a Medical Doctor within the Woman’s Health Sciences Department, Gynecology and Obstetrics Section at the Polytechnic University of Marche, Ancona, Italy.
His expertise includes Obstetrics, Gynecologic Oncology, Gynaecological Surgery and Laparoscopic Surgery.
I am a Professor of Biology at Toklyo Medical and Dental University. My research interest lies in the molecular and cellular basis of development and reproduction, two fundamental processes for all multicellular organisms. I am particularly interested in the cell and tissue communications that regulate these processes. In embryonic development, interactions between tissues of different cell lineages drive organ formation by activating genetic and epigenetic programs for tissue patterning and cellular differentiation. Tissue interaction also plays a fundamental role in mammalian reproduction as it mediates the actions of sex steroid hormones in reproductive organs. Deregulation of signaling pathways that control tissue communications could lead to conditions such as cancer. Thus, I also investigate the molecular pathogenesis of disorders in reproductive and hormone-target organs. Since mammalian development and reproductive functions are controlled by complex crosstalk among multiple tissues, organs, and systems, we primarily use in vivo mouse models for the investigation.
Understanding the molecular mechanisms underlying the fundamental process of life is a goal of our research. In addition, our research also aims to improve human health through translational research based on the knowledge obtained through basic research.
Dr Aya Mousa is a NHMRC biomedical research fellow and the Head of Diabetes, Metabolic and Reproductive Health research at the Monash Centre for Health Research and Implementation (MCHRI), Monash University.
Dr Mousa leads a team at MCHRI focusing on diabetes, metabolic and reproductive disorders, which includes work in obesity, type 1 and type 2 diabetes, polycystic ovary syndrome, and in pregnancy including gestational diabetes and the cross-talk between metabolic and reproductive disorders.
I received my PhD in Reproductive Endocrinology from University of Madras, India where I studied the molecular mechanism underlying the repression of follicle stimulating hormone receptor and androgen receptor in Sertoli cells of F1 progeny rats with gestational exposure to hexavalent chromium. I have successfully attained inter-laboratory collaboration to study the effect of gestational exposure to excess hexavalent chromium on insulin signaling molecules and glucose homeostasis in F1 progeny rats. Currently, my research focus is to understand the role of gonadal macrophage polarization in reproductive dysfunction associated with hypertension in both men and women.